A range of private companies sell products that are purported to flag patients in the early stages of sepsis to get them treatment quicker. But a lack of research plagues what could be a powerful tool for health systems, and some are pushing for more governance and even FDA involvement.
from Section Page News - Modern Healthcare https://ift.tt/2WlSSF0